From: Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
 | VH | VL | |||
---|---|---|---|---|---|
scFv | V | D | J | V | J |
RCA1 | IGHV1-69*10 | IGHD3-10*01 | IGHJ4*02 | IGKV1-NL1*01 | IGKJ1*01 |
RCA-8 | IGHV4-b*01 | IGHD1-7*01 | IGHJ5*02 | IGKV1-18*01 | IGKJ2*01 |
RCA4 | IGHV3-23*01 | IGHD3-10*01 | IGHJ4*02 | IGKV1-17*01 | IGKJ4*01 |
RCA23 | IGHV1-69*04 | IGHD1-1*01 | IGHJ4*02 | IGKV3-15*01 | IGKJ2*03 |
RCA31 | IGHV4-34*13 | IGHD2-8*02 | IGHJ4*02 | IGKV1-39*01 | IGKJ2*01 |
RCA35 | IGHV3-23*01 | IGHD3-10*02 | IGHJ5*02 | IGKV1-9*01 | IGKJ3*01 |
RCA38 | IGHV4-28*01 | IGHD6-13*01 | IGHJ5*02 | IGKV1-16*01 | IGKJ1*01 |
RCA43 | IGHV3-11*01 | IGHD5-12*01 | IGHJ4*02 | IGKV1-17*01 | IGKJ4*01 |
RCA44 | IGHV3-74*01 | IGHD3-10*02 | IGHJ5*02 | IGKV1-9*01 | IGKJ3*01 |